Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with recent stroke. - Telmisartan in Acute Stroke

Research Innovation Services, University of Nottingham0 个研究点目标入组 34 人开始时间: 2006年10月31日最近更新: 2019年2月28日

试验速览

暂无简介。

•Patients must be 18 years of age or over
•Onset date of stroke is less than 5 days.
•Systolic BP >140mmHg.
•Anterior circulation stroke
•Persisting stroke symptoms at time of enrolment or visible corresponding stroke lesion on CT
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Less than 18 years of age
•Normotension or hypotension (systolic less than 140mmHg)
•Onset date more than 5 days
•Coma (Scandinavian Stroke Scale (SSS) <4)
•Patients who are of childbearing potential, pregnant or breastfeeding
•Known bilateral renal artery stenosis (or unilateral in a single kidney)
•TIA (defined by symptoms resolved in 24 hours with a normal CT scan)
•Posterior circulation stroke
•Dysphagia with no enteral access
•Chest infection requiring continuous oxygen therapy
•COPD requiring regular inhalers/nebulisers (mild COPD requiring PRN bronchodilators permitted)
•Known hypersensitivity to telmisartan or angiotensin receptor blockers

发起方

Research Innovation Services, University of Nottingham